Newt’s World Episode 75: COVID-19 Health Care Breakthroughs – Clinical Trials Hydroxychloroquine

As doctors and clinicians continue to look for breakthroughs in treatments for COVID-19, could the anti-malarial drug, hydroxychloroquine, prove to be a possible prophylactic?  Newt talks with Dr. David Pearce of Sanford Health.  Sanford Health is conducting the first controlled hydroxychloroquine clinical trial in the United States.][vc

GUEST – DR. DAVID PEARCE
ARTICLES

Sanford Health to lead clinical trial for COVID-19 treatment

COVID-19 FAQs: Your clinical trial questions answered – Stanford Health

FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems – FDA

Emergency Use Authorization for Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied From the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease – FDA